| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 171 | 2024 | 4875 | 10.510 |
Why?
|
| Neoplasms, Glandular and Epithelial | 45 | 2017 | 487 | 5.620 |
Why?
|
| Endometriosis | 34 | 2024 | 871 | 5.430 |
Why?
|
| CA-125 Antigen | 12 | 2021 | 280 | 3.370 |
Why?
|
| Dysmenorrhea | 7 | 2024 | 98 | 2.210 |
Why?
|
| Leiomyoma | 12 | 2023 | 654 | 1.770 |
Why?
|
| Case-Control Studies | 101 | 2024 | 22041 | 1.640 |
Why?
|
| Carcinoma, Endometrioid | 8 | 2019 | 276 | 1.470 |
Why?
|
| Pelvic Pain | 6 | 2024 | 298 | 1.400 |
Why?
|
| Polymorphism, Single Nucleotide | 67 | 2024 | 15766 | 1.290 |
Why?
|
| Uterine Neoplasms | 11 | 2023 | 1434 | 1.210 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2019 | 378 | 0.990 |
Why?
|
| Cystadenocarcinoma, Serous | 9 | 2023 | 475 | 0.960 |
Why?
|
| Genetic Predisposition to Disease | 55 | 2024 | 17766 | 0.930 |
Why?
|
| Reproductive History | 7 | 2022 | 210 | 0.920 |
Why?
|
| Parity | 14 | 2024 | 925 | 0.890 |
Why?
|
| Adenocarcinoma, Clear Cell | 5 | 2019 | 218 | 0.880 |
Why?
|
| Menstrual Cycle | 6 | 2022 | 536 | 0.860 |
Why?
|
| Female | 231 | 2024 | 391011 | 0.840 |
Why?
|
| Adenocarcinoma, Mucinous | 6 | 2019 | 517 | 0.840 |
Why?
|
| New England | 10 | 2021 | 1045 | 0.840 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 4 | 2019 | 194 | 0.820 |
Why?
|
| Telomere | 3 | 2020 | 934 | 0.780 |
Why?
|
| Risk Factors | 96 | 2024 | 74269 | 0.770 |
Why?
|
| Intrauterine Devices | 2 | 2021 | 114 | 0.770 |
Why?
|
| Premenopause | 9 | 2019 | 1039 | 0.720 |
Why?
|
| Nurses | 10 | 2023 | 2468 | 0.720 |
Why?
|
| Contraceptives, Oral | 9 | 2024 | 554 | 0.710 |
Why?
|
| Talc | 4 | 2022 | 48 | 0.680 |
Why?
|
| Early Detection of Cancer | 7 | 2019 | 3215 | 0.670 |
Why?
|
| Hysterectomy | 7 | 2023 | 901 | 0.660 |
Why?
|
| Blood Proteins | 1 | 2024 | 1172 | 0.630 |
Why?
|
| Sterilization, Tubal | 4 | 2024 | 80 | 0.630 |
Why?
|
| Postmenopause | 8 | 2021 | 2503 | 0.620 |
Why?
|
| Risk | 26 | 2021 | 9629 | 0.620 |
Why?
|
| Middle Aged | 115 | 2024 | 220175 | 0.590 |
Why?
|
| Menopause | 5 | 2021 | 1640 | 0.590 |
Why?
|
| Logistic Models | 31 | 2024 | 13311 | 0.590 |
Why?
|
| Analgesics | 3 | 2021 | 1066 | 0.580 |
Why?
|
| Humans | 238 | 2024 | 760261 | 0.580 |
Why?
|
| Adult | 103 | 2024 | 219847 | 0.560 |
Why?
|
| Odds Ratio | 26 | 2024 | 9712 | 0.540 |
Why?
|
| Genetic Variation | 10 | 2016 | 6540 | 0.540 |
Why?
|
| Estrogen Replacement Therapy | 6 | 2021 | 1207 | 0.530 |
Why?
|
| Telomerase | 5 | 2019 | 747 | 0.530 |
Why?
|
| Menarche | 3 | 2022 | 529 | 0.510 |
Why?
|
| Genotype | 41 | 2019 | 12959 | 0.510 |
Why?
|
| Platinum | 1 | 2016 | 223 | 0.490 |
Why?
|
| Genome-Wide Association Study | 27 | 2024 | 12602 | 0.480 |
Why?
|
| Laparoscopy | 3 | 2024 | 2155 | 0.460 |
Why?
|
| Carcinoma | 6 | 2023 | 2334 | 0.450 |
Why?
|
| Powders | 1 | 2013 | 80 | 0.440 |
Why?
|
| Breast Feeding | 2 | 2020 | 1356 | 0.440 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1828 | 0.440 |
Why?
|
| Alleles | 19 | 2022 | 6900 | 0.430 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 6 | 2021 | 2282 | 0.420 |
Why?
|
| Receptors, Progesterone | 6 | 2016 | 1122 | 0.420 |
Why?
|
| Endometrial Neoplasms | 4 | 2017 | 1361 | 0.420 |
Why?
|
| Uterine Artery Embolization | 2 | 2023 | 59 | 0.420 |
Why?
|
| Mucin-1 | 3 | 2021 | 539 | 0.410 |
Why?
|
| Prospective Studies | 42 | 2024 | 54263 | 0.410 |
Why?
|
| Public Opinion | 1 | 2016 | 481 | 0.410 |
Why?
|
| Dietary Fats | 2 | 2020 | 1992 | 0.360 |
Why?
|
| Smoking | 7 | 2024 | 9070 | 0.360 |
Why?
|
| Vitamin B 6 | 1 | 2011 | 233 | 0.360 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 27 | 0.360 |
Why?
|
| Dairy Products | 2 | 2020 | 494 | 0.350 |
Why?
|
| Survival Rate | 9 | 2021 | 12806 | 0.350 |
Why?
|
| Folic Acid | 3 | 2023 | 1309 | 0.350 |
Why?
|
| Aged | 63 | 2024 | 168995 | 0.350 |
Why?
|
| Proportional Hazards Models | 24 | 2024 | 12532 | 0.340 |
Why?
|
| Membrane Proteins | 5 | 2021 | 7854 | 0.340 |
Why?
|
| Genetic Loci | 6 | 2017 | 2618 | 0.340 |
Why?
|
| Proteomics | 4 | 2024 | 3810 | 0.330 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2010 | 275 | 0.330 |
Why?
|
| Pregnancy | 22 | 2023 | 29725 | 0.330 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 125 | 0.330 |
Why?
|
| Methionine | 1 | 2011 | 569 | 0.330 |
Why?
|
| Breast Neoplasms | 19 | 2022 | 21065 | 0.320 |
Why?
|
| Women's Health | 6 | 2022 | 2057 | 0.320 |
Why?
|
| Life Style | 3 | 2017 | 3888 | 0.320 |
Why?
|
| Vitamin B 12 | 1 | 2011 | 522 | 0.310 |
Why?
|
| Survival Analysis | 7 | 2021 | 10185 | 0.310 |
Why?
|
| Cohort Studies | 30 | 2024 | 41317 | 0.310 |
Why?
|
| Genetic Association Studies | 12 | 2019 | 2716 | 0.310 |
Why?
|
| Pain | 4 | 2023 | 5066 | 0.300 |
Why?
|
| Young Adult | 27 | 2024 | 58673 | 0.300 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 415 | 0.300 |
Why?
|
| Body Size | 2 | 2007 | 462 | 0.300 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3561 | 0.290 |
Why?
|
| New Hampshire | 6 | 2016 | 173 | 0.290 |
Why?
|
| Food | 1 | 2012 | 772 | 0.290 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1882 | 0.280 |
Why?
|
| Neoplasm Invasiveness | 12 | 2019 | 3618 | 0.280 |
Why?
|
| Mendelian Randomization Analysis | 5 | 2019 | 989 | 0.280 |
Why?
|
| Anovulation | 1 | 2006 | 54 | 0.280 |
Why?
|
| Hydrocortisone | 3 | 2019 | 1798 | 0.280 |
Why?
|
| Adolescent | 27 | 2024 | 87747 | 0.280 |
Why?
|
| Prognosis | 17 | 2021 | 29636 | 0.270 |
Why?
|
| Ovulation | 1 | 2007 | 181 | 0.260 |
Why?
|
| Alcohol Drinking | 3 | 2018 | 4012 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 368 | 0.260 |
Why?
|
| Reproduction | 1 | 2010 | 647 | 0.260 |
Why?
|
| Caffeine | 3 | 2024 | 701 | 0.250 |
Why?
|
| Hair | 2 | 2018 | 492 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4357 | 0.240 |
Why?
|
| Carotenoids | 1 | 2007 | 620 | 0.240 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2008 | 89 | 0.230 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 257 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2024 | 1920 | 0.230 |
Why?
|
| Epidemiologic Research Design | 2 | 2018 | 368 | 0.230 |
Why?
|
| Diet | 6 | 2022 | 8008 | 0.230 |
Why?
|
| Antigens, Neoplasm | 3 | 2021 | 1999 | 0.230 |
Why?
|
| Europe | 6 | 2017 | 3433 | 0.230 |
Why?
|
| Menstruation Disturbances | 1 | 2005 | 144 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2018 | 8498 | 0.230 |
Why?
|
| Anticarcinogenic Agents | 2 | 2017 | 249 | 0.230 |
Why?
|
| Vitamin D | 3 | 2019 | 3293 | 0.220 |
Why?
|
| Menstruation | 1 | 2005 | 307 | 0.220 |
Why?
|
| Mucins | 1 | 2007 | 568 | 0.220 |
Why?
|
| Quantitative Trait Loci | 6 | 2018 | 2101 | 0.220 |
Why?
|
| Follow-Up Studies | 14 | 2022 | 39254 | 0.220 |
Why?
|
| BRCA2 Protein | 4 | 2017 | 797 | 0.220 |
Why?
|
| Infertility | 3 | 2023 | 655 | 0.210 |
Why?
|
| Anthropometry | 1 | 2007 | 1348 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2016 | 347 | 0.210 |
Why?
|
| Tea | 1 | 2024 | 284 | 0.210 |
Why?
|
| Pain, Postoperative | 2 | 2024 | 1718 | 0.210 |
Why?
|
| Fertility | 4 | 2022 | 772 | 0.210 |
Why?
|
| Cyclooxygenase 2 | 2 | 2018 | 600 | 0.210 |
Why?
|
| Age Factors | 9 | 2021 | 18415 | 0.210 |
Why?
|
| Dyspareunia | 1 | 2022 | 50 | 0.200 |
Why?
|
| Pesticide Residues | 1 | 2022 | 95 | 0.200 |
Why?
|
| Risk Assessment | 16 | 2024 | 24086 | 0.200 |
Why?
|
| Progestins | 2 | 2021 | 303 | 0.190 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 25928 | 0.190 |
Why?
|
| Peritoneal Diseases | 1 | 2021 | 76 | 0.190 |
Why?
|
| United States | 28 | 2024 | 72363 | 0.190 |
Why?
|
| Transcytosis | 1 | 2021 | 45 | 0.180 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2441 | 0.180 |
Why?
|
| Infertility, Female | 1 | 2006 | 760 | 0.180 |
Why?
|
| Menopause, Premature | 1 | 2022 | 125 | 0.180 |
Why?
|
| Eating | 2 | 2020 | 1538 | 0.180 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2021 | 155 | 0.180 |
Why?
|
| Aspirin | 4 | 2023 | 3365 | 0.170 |
Why?
|
| Action Potentials | 1 | 2007 | 1814 | 0.170 |
Why?
|
| Pesticides | 1 | 2022 | 292 | 0.170 |
Why?
|
| Mexican Americans | 1 | 2021 | 165 | 0.170 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2022 | 185 | 0.170 |
Why?
|
| Coffee | 1 | 2024 | 582 | 0.170 |
Why?
|
| Polymorphism, Genetic | 5 | 2013 | 4286 | 0.170 |
Why?
|
| DNA, Neoplasm | 3 | 2015 | 1745 | 0.170 |
Why?
|
| Antioxidants | 1 | 2007 | 1668 | 0.170 |
Why?
|
| Dietary Supplements | 2 | 2014 | 3389 | 0.170 |
Why?
|
| Leisure Activities | 1 | 2021 | 306 | 0.170 |
Why?
|
| Mastocytosis, Systemic | 1 | 2021 | 102 | 0.170 |
Why?
|
| Estrogen Receptor alpha | 2 | 2016 | 580 | 0.170 |
Why?
|
| Labor Stage, First | 1 | 2019 | 20 | 0.160 |
Why?
|
| Models, Neurological | 1 | 2007 | 1758 | 0.160 |
Why?
|
| Labor Onset | 1 | 2019 | 17 | 0.160 |
Why?
|
| Autoantibodies | 2 | 2018 | 2119 | 0.160 |
Why?
|
| Receptors, Androgen | 1 | 2005 | 1075 | 0.160 |
Why?
|
| Recreation | 2 | 2016 | 120 | 0.160 |
Why?
|
| Oncogene Proteins | 2 | 2022 | 721 | 0.160 |
Why?
|
| Biological Specimen Banks | 1 | 2024 | 776 | 0.160 |
Why?
|
| Haplotypes | 5 | 2009 | 2764 | 0.160 |
Why?
|
| Area Under Curve | 3 | 2017 | 1635 | 0.160 |
Why?
|
| Thymidylate Synthase | 1 | 2018 | 72 | 0.160 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 130 | 0.160 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 98 | 0.160 |
Why?
|
| Dehydroepiandrosterone | 1 | 2019 | 257 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9274 | 0.160 |
Why?
|
| RNA, Antisense | 1 | 2018 | 136 | 0.150 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2018 | 52 | 0.150 |
Why?
|
| Oligomenorrhea | 1 | 2017 | 42 | 0.150 |
Why?
|
| Incidence | 13 | 2018 | 21378 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2021 | 1256 | 0.150 |
Why?
|
| Nutrition Assessment | 1 | 2021 | 725 | 0.150 |
Why?
|
| Tissue Array Analysis | 2 | 2016 | 551 | 0.150 |
Why?
|
| Pelvis | 1 | 2022 | 743 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2022 | 708 | 0.140 |
Why?
|
| 5-Methylcytosine | 1 | 2017 | 146 | 0.140 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 978 | 0.140 |
Why?
|
| Exercise | 3 | 2021 | 5783 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2018 | 200 | 0.140 |
Why?
|
| Tasmania | 1 | 2016 | 4 | 0.140 |
Why?
|
| Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.140 |
Why?
|
| Keratin-13 | 1 | 2016 | 11 | 0.140 |
Why?
|
| Aged, 80 and over | 18 | 2021 | 58947 | 0.140 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1064 | 0.140 |
Why?
|
| Neoplasm Staging | 8 | 2023 | 11141 | 0.140 |
Why?
|
| Biotinidase | 1 | 2016 | 17 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2014 | 3185 | 0.140 |
Why?
|
| Inheritance Patterns | 1 | 2019 | 340 | 0.140 |
Why?
|
| Epidemiologic Studies | 4 | 2023 | 670 | 0.140 |
Why?
|
| Receptors, Calcitriol | 1 | 2019 | 359 | 0.140 |
Why?
|
| Dinoprostone | 1 | 2019 | 599 | 0.140 |
Why?
|
| Metformin | 1 | 2024 | 912 | 0.140 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 582 | 0.130 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 1727 | 0.130 |
Why?
|
| Fallopian Tube Diseases | 1 | 2016 | 60 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 6 | 2017 | 1375 | 0.130 |
Why?
|
| Multivariate Analysis | 8 | 2018 | 12156 | 0.130 |
Why?
|
| Comorbidity | 4 | 2024 | 10552 | 0.130 |
Why?
|
| Neoplasm Proteins | 5 | 2019 | 3613 | 0.130 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2019 | 284 | 0.130 |
Why?
|
| Abortion, Spontaneous | 1 | 2021 | 530 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2018 | 6210 | 0.130 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2019 | 698 | 0.130 |
Why?
|
| Codon, Terminator | 1 | 2015 | 125 | 0.130 |
Why?
|
| Hyperthyroidism | 1 | 2017 | 291 | 0.130 |
Why?
|
| RNA Editing | 1 | 2016 | 151 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2016 | 301 | 0.120 |
Why?
|
| Genitalia, Female | 1 | 2016 | 147 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2014 | 2486 | 0.120 |
Why?
|
| Abortion, Induced | 1 | 2021 | 460 | 0.120 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 191 | 0.120 |
Why?
|
| History, 21st Century | 1 | 2021 | 1576 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 1817 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3333 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13629 | 0.120 |
Why?
|
| Dihydrouracil Dehydrogenase (NADP) | 1 | 2014 | 17 | 0.120 |
Why?
|
| Hormone Replacement Therapy | 1 | 2020 | 756 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 810 | 0.120 |
Why?
|
| Mandibular Diseases | 1 | 2015 | 119 | 0.120 |
Why?
|
| Massachusetts | 6 | 2016 | 8805 | 0.120 |
Why?
|
| Regression Analysis | 3 | 2018 | 6361 | 0.120 |
Why?
|
| Linkage Disequilibrium | 4 | 2009 | 1996 | 0.120 |
Why?
|
| Exercise Therapy | 1 | 2021 | 920 | 0.120 |
Why?
|
| Parturition | 1 | 2018 | 445 | 0.110 |
Why?
|
| Motor Activity | 2 | 2021 | 2687 | 0.110 |
Why?
|
| Ovary | 3 | 2013 | 959 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1091 | 0.110 |
Why?
|
| Body Mass Index | 9 | 2019 | 12901 | 0.110 |
Why?
|
| Prostatic Neoplasms | 5 | 2019 | 11341 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1765 | 0.110 |
Why?
|
| Gonadotropins | 1 | 2014 | 241 | 0.110 |
Why?
|
| Boston | 2 | 2022 | 9282 | 0.110 |
Why?
|
| Acetaminophen | 2 | 2017 | 553 | 0.110 |
Why?
|
| Diethylstilbestrol | 1 | 2013 | 88 | 0.110 |
Why?
|
| Interleukin-1alpha | 1 | 2013 | 86 | 0.110 |
Why?
|
| Triglycerides | 1 | 2021 | 2476 | 0.110 |
Why?
|
| Cystadenoma, Serous | 1 | 2014 | 100 | 0.110 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 3149 | 0.110 |
Why?
|
| Longitudinal Studies | 5 | 2024 | 14482 | 0.110 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2019 | 628 | 0.110 |
Why?
|
| 4-Butyrolactone | 1 | 2013 | 62 | 0.110 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4404 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2777 | 0.110 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2016 | 306 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 330 | 0.110 |
Why?
|
| Acrylamide | 1 | 2013 | 59 | 0.110 |
Why?
|
| Protective Agents | 1 | 2014 | 150 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.100 |
Why?
|
| Lignans | 1 | 2013 | 84 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 192 | 0.100 |
Why?
|
| British Columbia | 2 | 2024 | 240 | 0.100 |
Why?
|
| Lactose | 1 | 2012 | 95 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2017 | 665 | 0.100 |
Why?
|
| Fallopian Tubes | 1 | 2013 | 178 | 0.100 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2012 | 68 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2020 | 1805 | 0.100 |
Why?
|
| Drug Resistance, Multiple | 1 | 2013 | 254 | 0.100 |
Why?
|
| Estradiol | 3 | 2023 | 1932 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2017 | 1085 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 1900 | 0.100 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 3758 | 0.100 |
Why?
|
| Confidence Intervals | 3 | 2009 | 2932 | 0.100 |
Why?
|
| BRCA1 Protein | 2 | 2017 | 1146 | 0.100 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2422 | 0.100 |
Why?
|
| ROC Curve | 2 | 2017 | 3568 | 0.100 |
Why?
|
| Alveolar Bone Loss | 1 | 2015 | 390 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 22066 | 0.100 |
Why?
|
| Body Height | 1 | 2018 | 1570 | 0.100 |
Why?
|
| Gene Expression Profiling | 7 | 2017 | 9388 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2013 | 419 | 0.090 |
Why?
|
| Luteal Phase | 1 | 2011 | 138 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2874 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2020 | 2415 | 0.090 |
Why?
|
| Lipids | 1 | 2022 | 3336 | 0.090 |
Why?
|
| Disease-Free Survival | 6 | 2017 | 6830 | 0.090 |
Why?
|
| Inflammation | 4 | 2024 | 10757 | 0.090 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 5793 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 730 | 0.090 |
Why?
|
| Vegetables | 3 | 2022 | 1198 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2023 | 6545 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 2018 | 0.090 |
Why?
|
| Stress, Psychological | 2 | 2018 | 4440 | 0.090 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2013 | 329 | 0.090 |
Why?
|
| ABO Blood-Group System | 1 | 2012 | 369 | 0.090 |
Why?
|
| Registries | 3 | 2023 | 8449 | 0.090 |
Why?
|
| Estrogens | 3 | 2023 | 1520 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2016 | 5230 | 0.090 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2010 | 63 | 0.090 |
Why?
|
| Obesity | 4 | 2019 | 12915 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2015 | 1729 | 0.080 |
Why?
|
| Vehicle Emissions | 1 | 2014 | 653 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1399 | 0.080 |
Why?
|
| Population Surveillance | 2 | 2017 | 2609 | 0.080 |
Why?
|
| Calcium, Dietary | 1 | 2012 | 531 | 0.080 |
Why?
|
| Waist-Hip Ratio | 1 | 2010 | 516 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 243 | 0.080 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3826 | 0.080 |
Why?
|
| Estrone | 1 | 2010 | 232 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2020 | 1387 | 0.080 |
Why?
|
| Androgens | 1 | 2016 | 1289 | 0.080 |
Why?
|
| DNA Ligases | 1 | 2009 | 82 | 0.080 |
Why?
|
| Abdominal Fat | 1 | 2010 | 223 | 0.080 |
Why?
|
| Actins | 1 | 2016 | 2049 | 0.080 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2009 | 114 | 0.080 |
Why?
|
| Microsatellite Repeats | 1 | 2011 | 786 | 0.080 |
Why?
|
| Gene Frequency | 4 | 2016 | 3605 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2008 | 85 | 0.080 |
Why?
|
| Aromatase | 1 | 2008 | 147 | 0.080 |
Why?
|
| Probability | 2 | 2018 | 2476 | 0.080 |
Why?
|
| Heterozygote | 5 | 2015 | 2797 | 0.080 |
Why?
|
| Neurons | 1 | 2007 | 9416 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 9590 | 0.080 |
Why?
|
| Health Surveys | 4 | 2021 | 4061 | 0.080 |
Why?
|
| Australia | 4 | 2014 | 1288 | 0.070 |
Why?
|
| Diet, Mediterranean | 1 | 2014 | 732 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2019 | 2064 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
| Bayes Theorem | 3 | 2022 | 2325 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 2927 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2823 | 0.070 |
Why?
|
| Waist Circumference | 1 | 2010 | 922 | 0.070 |
Why?
|
| Quality of Life | 3 | 2023 | 13300 | 0.070 |
Why?
|
| Social Class | 1 | 2016 | 2005 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2013 | 1521 | 0.070 |
Why?
|
| MicroRNAs | 3 | 2011 | 3784 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2009 | 714 | 0.070 |
Why?
|
| Signal Transduction | 5 | 2019 | 23363 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2008 | 565 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2804 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2018 | 9283 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2016 | 3207 | 0.070 |
Why?
|
| Lymphocytes | 1 | 2014 | 2612 | 0.060 |
Why?
|
| ras Proteins | 1 | 2011 | 1051 | 0.060 |
Why?
|
| Homozygote | 4 | 2014 | 1786 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 3763 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 3774 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 6067 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2010 | 1327 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2019 | 2880 | 0.060 |
Why?
|
| Melanoma | 2 | 2021 | 5695 | 0.060 |
Why?
|
| Mutation | 5 | 2017 | 29950 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2022 | 12762 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2016 | 3076 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2017 | 2809 | 0.060 |
Why?
|
| Age Distribution | 2 | 2007 | 2893 | 0.060 |
Why?
|
| Macrophages | 1 | 2018 | 5745 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5797 | 0.060 |
Why?
|
| Fertilization in Vitro | 1 | 2011 | 1292 | 0.060 |
Why?
|
| Proteins | 1 | 2018 | 6030 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2017 | 4494 | 0.050 |
Why?
|
| DNA Methylation | 4 | 2023 | 4374 | 0.050 |
Why?
|
| Body Weight | 2 | 2011 | 4613 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2014 | 2558 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 2250 | 0.050 |
Why?
|
| Algorithms | 3 | 2020 | 13967 | 0.050 |
Why?
|
| Child | 6 | 2023 | 79758 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3466 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 15740 | 0.050 |
Why?
|
| Cyclin E | 1 | 2022 | 157 | 0.050 |
Why?
|
| Sex Factors | 1 | 2016 | 10530 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2940 | 0.050 |
Why?
|
| Thionucleotides | 1 | 2002 | 112 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4938 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2002 | 119 | 0.050 |
Why?
|
| Prevalence | 4 | 2024 | 15687 | 0.050 |
Why?
|
| Social Support | 1 | 2011 | 2145 | 0.050 |
Why?
|
| Age of Onset | 2 | 2006 | 3302 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2023 | 270 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 2494 | 0.050 |
Why?
|
| Neutrophils | 1 | 2014 | 3770 | 0.050 |
Why?
|
| Air Pollution | 1 | 2014 | 2316 | 0.050 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2000 | 86 | 0.040 |
Why?
|
| Air Pollutants | 1 | 2014 | 2843 | 0.040 |
Why?
|
| Reference Values | 1 | 2007 | 4920 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Glutens | 1 | 2022 | 240 | 0.040 |
Why?
|
| Glycemic Index | 1 | 2022 | 396 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
| Time Factors | 6 | 2019 | 40133 | 0.040 |
Why?
|
| DNA | 1 | 2013 | 7236 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 1791 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3804 | 0.040 |
Why?
|
| Menorrhagia | 1 | 2019 | 60 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 631 | 0.040 |
Why?
|
| Gestational Age | 2 | 2018 | 3564 | 0.040 |
Why?
|
| Mycoplasma genitalium | 1 | 2019 | 12 | 0.040 |
Why?
|
| Cervical Ripening | 1 | 2019 | 18 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 459 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2016 | 2608 | 0.040 |
Why?
|
| Leucine | 1 | 2000 | 548 | 0.040 |
Why?
|
| Trans Fatty Acids | 1 | 2020 | 155 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2023 | 701 | 0.040 |
Why?
|
| Biopsy | 2 | 2021 | 6775 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6855 | 0.040 |
Why?
|
| Endometrium | 1 | 2021 | 403 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1061 | 0.040 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2019 | 95 | 0.040 |
Why?
|
| Emergency Nursing | 1 | 1998 | 42 | 0.040 |
Why?
|
| Hydro-Lyases | 1 | 2018 | 93 | 0.040 |
Why?
|
| Dietary Fiber | 1 | 2022 | 760 | 0.040 |
Why?
|
| Human papillomavirus 18 | 1 | 2019 | 126 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 803 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3665 | 0.040 |
Why?
|
| Creatinine | 1 | 2024 | 1906 | 0.040 |
Why?
|
| Self Report | 2 | 2021 | 3707 | 0.040 |
Why?
|
| Birth Weight | 1 | 2006 | 2094 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2023 | 80301 | 0.040 |
Why?
|
| Herpesvirus 2, Human | 1 | 2019 | 190 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1594 | 0.040 |
Why?
|
| Crisis Intervention | 1 | 1998 | 110 | 0.040 |
Why?
|
| Labor, Induced | 1 | 2019 | 151 | 0.040 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2019 | 190 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2022 | 893 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 1999 | 328 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10829 | 0.040 |
Why?
|
| Genome, Human | 1 | 2010 | 4416 | 0.040 |
Why?
|
| Chlamydia trachomatis | 1 | 2019 | 238 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 534 | 0.040 |
Why?
|
| Fruit | 1 | 2022 | 1162 | 0.040 |
Why?
|
| Human papillomavirus 16 | 1 | 2019 | 266 | 0.040 |
Why?
|
| Breast | 1 | 2006 | 1980 | 0.040 |
Why?
|
| Epithelium | 1 | 2021 | 1605 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4409 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 8595 | 0.030 |
Why?
|
| Pathology, Clinical | 1 | 2000 | 375 | 0.030 |
Why?
|
| Gene Expression | 2 | 2023 | 7592 | 0.030 |
Why?
|
| Disease Progression | 3 | 2021 | 13505 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2017 | 119 | 0.030 |
Why?
|
| Tyrosine | 1 | 2000 | 1440 | 0.030 |
Why?
|
| Nuchal Cord | 1 | 2015 | 5 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1737 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 661 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2000 | 911 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2017 | 343 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2020 | 1008 | 0.030 |
Why?
|
| Saliva | 1 | 2019 | 816 | 0.030 |
Why?
|
| Nursing Staff, Hospital | 1 | 1998 | 344 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1241 | 0.030 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 1500 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13249 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2017 | 747 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2013 | 2202 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 16905 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 2008 | 0.030 |
Why?
|
| Folic Acid Deficiency | 1 | 2014 | 117 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6310 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2019 | 1117 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2000 | 1612 | 0.030 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2013 | 62 | 0.030 |
Why?
|
| Environment | 1 | 2019 | 1118 | 0.030 |
Why?
|
| Epoxy Compounds | 1 | 2013 | 136 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 305 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 3107 | 0.030 |
Why?
|
| Vaccination | 2 | 2022 | 3360 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14656 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 11708 | 0.030 |
Why?
|
| Testosterone | 1 | 2023 | 2469 | 0.030 |
Why?
|
| Male | 8 | 2019 | 359413 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 463 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 3822 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 1673 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 1999 | 1044 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2000 | 1956 | 0.020 |
Why?
|
| Denmark | 1 | 2014 | 759 | 0.020 |
Why?
|
| Depression | 2 | 2023 | 8033 | 0.020 |
Why?
|
| Luciferases | 1 | 2013 | 716 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2013 | 264 | 0.020 |
Why?
|
| Lysine | 1 | 2015 | 1002 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10340 | 0.020 |
Why?
|
| Quality Control | 1 | 2013 | 827 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1531 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2087 | 0.020 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 118 | 0.020 |
Why?
|
| Hawaii | 1 | 2010 | 101 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1858 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2000 | 1822 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2021 | 4002 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 789 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5784 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2861 | 0.020 |
Why?
|
| Health Behavior | 1 | 2021 | 2621 | 0.020 |
Why?
|
| Morbidity | 1 | 2015 | 1765 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2014 | 1600 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2022 | 12100 | 0.020 |
Why?
|
| Burnout, Professional | 1 | 1998 | 703 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2023 | 11064 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3584 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 680 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2013 | 909 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 1999 | 2528 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2009 | 56 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2010 | 385 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2008 | 69 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 514 | 0.020 |
Why?
|
| Weight Gain | 1 | 2019 | 2347 | 0.020 |
Why?
|
| Pregnancy Rate | 1 | 2011 | 650 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 70 | 0.020 |
Why?
|
| Genomics | 1 | 2024 | 5790 | 0.020 |
Why?
|
| Binding Sites | 2 | 2011 | 6050 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 1441 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2008 | 188 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7072 | 0.020 |
Why?
|
| Overweight | 1 | 2019 | 2421 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5796 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 208 | 0.020 |
Why?
|
| Protein Binding | 2 | 2015 | 9336 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 1378 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2008 | 253 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 2128 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2011 | 769 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15626 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 3381 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 17628 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2128 | 0.020 |
Why?
|
| Animals | 4 | 2017 | 167940 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2023 | 64947 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2414 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2018 | 3728 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10434 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4573 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 1738 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4900 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8551 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 1843 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8487 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2008 | 698 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 652 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 671 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2008 | 613 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2014 | 2058 | 0.010 |
Why?
|
| Data Collection | 1 | 2014 | 3317 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2011 | 2918 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2283 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1344 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20048 | 0.010 |
Why?
|
| Anxiety | 1 | 2018 | 4532 | 0.010 |
Why?
|
| International Cooperation | 1 | 2010 | 1436 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 1134 | 0.010 |
Why?
|
| Computational Biology | 1 | 2015 | 3504 | 0.010 |
Why?
|
| Transfection | 1 | 2011 | 5782 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1135 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4317 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 6131 | 0.010 |
Why?
|
| Kinetics | 2 | 2000 | 6378 | 0.010 |
Why?
|
| Insulin | 1 | 2017 | 6592 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8621 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1892 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2010 | 2255 | 0.010 |
Why?
|
| Transaminases | 1 | 2002 | 196 | 0.010 |
Why?
|
| Chromatin | 1 | 2013 | 2939 | 0.010 |
Why?
|
| Biological Availability | 1 | 2002 | 395 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 4625 | 0.010 |
Why?
|
| Half-Life | 1 | 2002 | 652 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16543 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2013 | 3903 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 2000 | 116 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2000 | 348 | 0.010 |
Why?
|
| Emotions | 1 | 2011 | 2730 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1999 | 322 | 0.010 |
Why?
|
| Catalysis | 1 | 2000 | 775 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1999 | 410 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6797 | 0.010 |
Why?
|
| Tennessee | 1 | 1998 | 119 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18134 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5884 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 890 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 12447 | 0.010 |
Why?
|
| Students, Nursing | 1 | 1998 | 46 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 42034 | 0.010 |
Why?
|
| New York | 1 | 2000 | 874 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1694 | 0.010 |
Why?
|
| Safety | 1 | 2002 | 1149 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2235 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2000 | 1230 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1792 | 0.010 |
Why?
|
| Asthma | 1 | 2015 | 6167 | 0.010 |
Why?
|
| Protein Folding | 1 | 2000 | 867 | 0.010 |
Why?
|
| Organizational Policy | 1 | 1998 | 429 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1999 | 782 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1408 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1188 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 5039 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1999 | 1529 | 0.010 |
Why?
|
| Needs Assessment | 1 | 1998 | 1137 | 0.010 |
Why?
|
| Antibodies | 1 | 1999 | 2424 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 6543 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81216 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5429 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 26168 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13456 | 0.000 |
Why?
|
| Infant | 1 | 2009 | 36030 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 4546 | 0.000 |
Why?
|
| Patient Selection | 1 | 1999 | 4276 | 0.000 |
Why?
|
| Rats | 1 | 2000 | 23695 | 0.000 |
Why?
|
| Medicare | 1 | 2000 | 6771 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 1998 | 7809 | 0.000 |
Why?
|